-
公开(公告)号:US06503949B1
公开(公告)日:2003-01-07
申请号:US09572553
申请日:2000-05-16
申请人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Thøger Christensen , Behrend Frederik Lundt , Ulla Grove Sidelmann , Henning Thøgersen , Anthony L. Ling , Michael Bruno Plewe , Larry Kenneth Truesdale , Shenghua Shi
发明人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Thøger Christensen , Behrend Frederik Lundt , Ulla Grove Sidelmann , Henning Thøgersen , Anthony L. Ling , Michael Bruno Plewe , Larry Kenneth Truesdale , Shenghua Shi
IPC分类号: A01N3718
CPC分类号: C07D209/48 , C07B2200/07 , C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07C2602/42 , C07C2603/18 , C07C2603/68 , C07C2603/94 , C07D209/08 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04
摘要: Disclosed is a novel class of compounds of formula (I) wherein V, A, Y, Z, R1, E, X and D are as defined in the specification. These compounds act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor, the compounds are suitable for treating or preventing glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
摘要翻译: 公开了一类新的式(I)化合物,其中V,A,Y,Z,R 1,E,X和D如说明书中所定义。 这些化合物用于拮抗胰高血糖素激素对胰高血糖素受体的作用。 由于其拮抗胰高血糖素受体的作用,该化合物适用于治疗或预防胰高血糖素介导的病症和疾病如高血糖症,1型糖尿病,2型糖尿病和肥胖症。
-
公开(公告)号:US06875760B2
公开(公告)日:2005-04-05
申请号:US10233851
申请日:2002-08-30
申请人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Inge Thøger Christensen , Behrend Frederik Lundt , Ulla Grove Sidelmann , Henning Thøgersen , Anthony L. Ling , Michael Bruno Plewe , Larry Kenneth Truesdale , Anker Steen Jøgensen , Janos Tibor Kodra , Shenghua Shi
发明人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Inge Thøger Christensen , Behrend Frederik Lundt , Ulla Grove Sidelmann , Henning Thøgersen , Anthony L. Ling , Michael Bruno Plewe , Larry Kenneth Truesdale , Anker Steen Jøgensen , Janos Tibor Kodra , Shenghua Shi
IPC分类号: C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07D209/08 , C07D209/48 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04 , A61K31/33 , A61K31/695 , C07D257/00
CPC分类号: C07D209/48 , C07B2200/07 , C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07C2602/42 , C07C2603/18 , C07C2603/68 , C07C2603/94 , C07D209/08 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04
摘要: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
-
公开(公告)号:US20090143592A1
公开(公告)日:2009-06-04
申请号:US11949075
申请日:2007-12-03
申请人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Thoger Christensen , Behrend Frederik Lundt , Ulla Grove Sidelmann , Henning Thogersen , Anthony L. Ling , Michael Bruno Plewe , Larry Kenneth Truesdale , Anker Steen Jogensen , Janos Tibor Kodra , Shenghua Shi
发明人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Thoger Christensen , Behrend Frederik Lundt , Ulla Grove Sidelmann , Henning Thogersen , Anthony L. Ling , Michael Bruno Plewe , Larry Kenneth Truesdale , Anker Steen Jogensen , Janos Tibor Kodra , Shenghua Shi
IPC分类号: C07D211/88 , C07D257/06 , C07D333/24 , C07C57/62
CPC分类号: C07D209/48 , C07B2200/07 , C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07C2602/42 , C07C2603/18 , C07C2603/68 , C07C2603/94 , C07D209/08 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04
摘要: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
摘要翻译: 一类新颖的化合物,其作用是拮抗胰高血糖素激素对胰高血糖素受体的作用。 由于它们对胰高血糖素受体的拮抗作用,所述化合物可适用于治疗和/或预防任何胰高血糖素介导的病症和疾病如高血糖症,1型糖尿病,2型糖尿病和肥胖症。
-
公开(公告)号:US06613942B1
公开(公告)日:2003-09-02
申请号:US09220003
申请日:1998-12-23
申请人: Anthony Ling , Vlad Gregor , Javier Gonzalez , Yufeng Hong , Dan Kiel , Atsuo Kuki , Shenghua Shi , Lars Naerum , Peter Madsen , Christian Sams , Jesper Lau , Michael Bruno Plewe , Jun Feng , Min Teng , Michael David Johnson , Kimberly Ann Teston , Ulla Grove Sidelmann , Lotte Bjerre Knudsen
发明人: Anthony Ling , Vlad Gregor , Javier Gonzalez , Yufeng Hong , Dan Kiel , Atsuo Kuki , Shenghua Shi , Lars Naerum , Peter Madsen , Christian Sams , Jesper Lau , Michael Bruno Plewe , Jun Feng , Min Teng , Michael David Johnson , Kimberly Ann Teston , Ulla Grove Sidelmann , Lotte Bjerre Knudsen
IPC分类号: C07C23300
CPC分类号: C07D295/192 , C07C251/86 , C07C255/29 , C07C271/12 , C07C271/22 , C07C271/24 , C07C271/28 , C07C309/65 , C07C311/16 , C07C311/20 , C07C311/49 , C07C317/28 , C07C323/45 , C07C323/60 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07D209/08 , C07D209/48 , C07D209/86 , C07D213/30 , C07D213/80 , C07D215/12 , C07D215/26 , C07D231/12 , C07D295/135 , C07D295/185 , C07D295/26 , C07D307/12 , C07D307/52 , C07D307/84 , C07D309/06 , C07D317/58 , C07D333/24 , C07D401/06 , C07D405/06 , C07D409/06
摘要: Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof are disclosed. The compounds act to antagonize the action of the glucagon peptide hormone.
摘要翻译: 公开了包含中心酰肼基序的非肽化合物及其合成方法。 该化合物起拮抗胰高血糖素肽激素的作用。
-
公开(公告)号:US20050203108A1
公开(公告)日:2005-09-15
申请号:US10980199
申请日:2004-11-03
申请人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Christensen , Behrend Lundt , Ulla Sidelmann , Henning Thogersen , Anthony Ling , Michael Plewe , Larry Truesdale , Anker Jogensen , Janos Kodra , Shenghua Shi
发明人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Christensen , Behrend Lundt , Ulla Sidelmann , Henning Thogersen , Anthony Ling , Michael Plewe , Larry Truesdale , Anker Jogensen , Janos Kodra , Shenghua Shi
IPC分类号: C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07D209/08 , C07D209/48 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04 , A61K31/519 , A61K31/415 , A61K31/445
CPC分类号: C07D209/48 , C07B2200/07 , C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07C2602/42 , C07C2603/18 , C07C2603/68 , C07C2603/94 , C07D209/08 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04
摘要: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
摘要翻译: 一类新颖的化合物,其作用是拮抗胰高血糖素激素对胰高血糖素受体的作用。 由于它们对胰高血糖素受体的拮抗作用,所述化合物可适用于治疗和/或预防任何胰高血糖素介导的病症和疾病如高血糖症,1型糖尿病,2型糖尿病和肥胖症。
-
公开(公告)号:US06953812B2
公开(公告)日:2005-10-11
申请号:US10372536
申请日:2003-02-24
申请人: Anker Steen Jorgensen , Inge Thoger Christensen , Janos Tibor Kodra , Christian Sams , Carsten Behrens , Peter Madsen , Jesper Lau
发明人: Anker Steen Jorgensen , Inge Thoger Christensen , Janos Tibor Kodra , Christian Sams , Carsten Behrens , Peter Madsen , Jesper Lau
IPC分类号: C07C237/42 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/42 , C07C317/42 , C07C323/44 , C07D209/08 , C07D209/42 , C07D209/48 , C07D213/40 , C07D213/75 , C07D213/82 , C07D257/04 , C07D263/56 , C07D263/57 , C07D271/06 , C07D277/28 , C07D277/66 , C07D277/82 , C07D307/68 , C07D319/08 , C07D333/20 , C07D333/36 , C07D333/68 , C07D513/04 , A01N43/06
CPC分类号: C07D209/48 , C07C237/42 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/42 , C07C317/42 , C07C323/44 , C07C2601/14 , C07C2601/16 , C07D209/08 , C07D209/42 , C07D213/40 , C07D213/75 , C07D213/82 , C07D257/04 , C07D263/57 , C07D271/06 , C07D277/28 , C07D277/66 , C07D277/82 , C07D307/68 , C07D319/08 , C07D333/20 , C07D333/36 , C07D333/68 , C07D513/04
摘要: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity.
摘要翻译: 一类新颖的化合物,其作用是拮抗胰高血糖素激素对胰高血糖素受体的作用。 由于它们对胰高血糖素受体的拮抗作用,这些化合物可能适用于治疗和/或预防任何疾病和病症,其中胰高血糖素拮抗作用是有益的,例如高血糖症,1型糖尿病,2型糖尿病, 脂质代谢,如血脂异常和肥胖。
-
公开(公告)号:US06562807B2
公开(公告)日:2003-05-13
申请号:US09888137
申请日:2001-06-22
申请人: Anker Steen Jorgensen , Inge Thoger Christensen , Janos Tibor Kodra , Christian Sams , Carsten Behrens , Peter Madsen , Jesper Lau
发明人: Anker Steen Jorgensen , Inge Thoger Christensen , Janos Tibor Kodra , Christian Sams , Carsten Behrens , Peter Madsen , Jesper Lau
IPC分类号: A61K31555
CPC分类号: C07D209/48 , C07C237/42 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/42 , C07C317/42 , C07C323/44 , C07C2601/14 , C07C2601/16 , C07D209/08 , C07D209/42 , C07D213/40 , C07D213/75 , C07D213/82 , C07D257/04 , C07D263/57 , C07D271/06 , C07D277/28 , C07D277/66 , C07D277/82 , C07D307/68 , C07D319/08 , C07D333/20 , C07D333/36 , C07D333/68 , C07D513/04
摘要: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity.
-
公开(公告)号:US20060166197A1
公开(公告)日:2006-07-27
申请号:US10507842
申请日:2003-03-14
申请人: Alex Gouliaev , Justin Ho , Jakob Felding , Christian Sams , Henrik Pedersen , Kim Jensen , Anders Hansen , Mikkel Lundorf , Gitte Husemoen , Thomas Franch , Thomas Thisted
发明人: Alex Gouliaev , Justin Ho , Jakob Felding , Christian Sams , Henrik Pedersen , Kim Jensen , Anders Hansen , Mikkel Lundorf , Gitte Husemoen , Thomas Franch , Thomas Thisted
IPC分类号: C40B40/08 , C07H21/02 , C07F9/6512
CPC分类号: C07D405/04 , C07B2200/11 , C07F9/65586 , C07F9/65616 , C07H21/00 , C07H21/02 , C07H23/00 , C12N15/1068 , C12P19/34 , C40B40/00
摘要: A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is disclosed. The building block can be designed with an adjustable transferability taking into account the components of the building block. The building block may be used in the generation of a single complex or libraries of different complexes, wherein the complex comprises an encoded molecule linked to an encoding element. Libraries of complexes are useful in the quest for pharmaceutically active compounds.
摘要翻译: 具有转移遗传信息的双重能力的构建块,例如, 通过识别编码元件并将功能实体传送到接收者反应组。 构建块可以设计成具有可调节的可转移性,同时考虑到构件的部件。 构建单元可以用于生成单个复合体或不同复合物的文库,其中复合物包含与编码元件连接的编码分子。 复合物库可用于寻求药物活性化合物。
-
公开(公告)号:US20050221318A1
公开(公告)日:2005-10-06
申请号:US10507599
申请日:2003-03-14
申请人: Alex Gouliaev , Henrik Pedersen , Kim Jensen , Anders Hansen , Christian Sams , Jakob Felding
发明人: Alex Gouliaev , Henrik Pedersen , Kim Jensen , Anders Hansen , Christian Sams , Jakob Felding
IPC分类号: C07B61/00 , C07D405/04 , C07H21/00 , C07H23/00 , C12N15/10 , C12Q1/68 , G01N33/53 , G01N33/543
CPC分类号: C07D405/04 , C07H21/00 , C07H23/00 , C12N15/1068 , C40B40/00 , G01N33/54353
摘要: A building block having the dual capabilities of recognising an encoding element and transferring a functional entity to a recipient reactive group is disclosed. The building block may be used in the generation of a single complex or libraries of different complexes, wherein the complex comprises an encoded molecule linked to an encoding element. Libraries of complexes are useful in the quest for pharmaceutically active compounds.
摘要翻译: 公开了具有识别编码元件并将功能实体传送到接收者反应组的双重能力的构建块。 构建单元可以用于生成单个复合体或不同复合物的文库,其中复合物包含与编码元件连接的编码分子。 复合物库可用于寻求药物活性化合物。
-
10.
公开(公告)号:US20050176948A1
公开(公告)日:2005-08-11
申请号:US10507936
申请日:2003-03-14
申请人: Alex Gouliaev , Henrik Pedersen , Thomas Thisted , Mikkel Lundorf , Christian Sams , Thomas Franch , Gitte Husemoen , Justin Ho
发明人: Alex Gouliaev , Henrik Pedersen , Thomas Thisted , Mikkel Lundorf , Christian Sams , Thomas Franch , Gitte Husemoen , Justin Ho
IPC分类号: C07B61/00 , C07D405/04 , C07F9/6558 , C07F9/6561 , C07H21/00 , C07H21/02 , C07H23/00 , C12N15/10 , C12P19/34
CPC分类号: C07D405/04 , C07B2200/11 , C07F9/65586 , C07F9/65616 , C07H21/00 , C07H21/02 , C07H23/00 , C12N15/1068 , C12P19/34 , C40B40/00
摘要: A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is diclosed. The building block can be designed with an adjustable transferability taking into account the components of the building block. The building block may be used in the generation of a single complex or libraries of different complexes, wherein the complex comprises an encoded molecule linked to an encoding element. Libraries of complexes are useful in the quest for pharmaceutically active compounds.
摘要翻译: 具有转移遗传信息的双重能力的构建块,例如, 通过识别编码元素并将功能实体传送到接收者反应组被关闭。 构建块可以设计成具有可调节的可转移性,同时考虑到构件的部件。 构建单元可以用于生成单个复合体或不同复合物的文库,其中复合物包含与编码元件连接的编码分子。 复合物库可用于寻求药物活性化合物。
-
-
-
-
-
-
-
-
-